Jefferies Upgrades Abivax to Buy, Raises Price Target to $158
Benzinga Newsdesk 4 months ago
NewsUpgradesAnalyst RatingsPrice Target
Jefferies analyst Faisal Khurshid upgrades Abivax (NASDAQ:ABVX) from Hold to Buy and raises the price target from $108 to $158.
Jefferies analyst Faisal Khurshid upgrades Abivax (NASDAQ:ABVX) from Hold to Buy and raises the price target from $108 to $158.